A review of the key issues associated with the commercialization of biobanks

Timothy Caulfield, Sarah Burningham, Yann Joly, Zubin Master, Mahsa Shabani, Pascal Borry, Allan Becker, Michael Burgess, Kathryn Calder, Christine Critchley, Kelly Edwards, Stephanie M. Fullerton, Herbert Gottweis, Robyn Hyde-Lay, Judy Illes, Rosario Isasi, Kazuto Kato, Jane Kaye, Bartha Knoppers, John LynchAmy McGuire, Eric Meslin, Dianne Nicol, Kieran O'Doherty, Ubaka Ogbogu, Margaret Otlowski, Daryl Pullman, Nola Ries, Chris Scott, Malcolm Sears, Helen Wallace, Ma'n H. Zawati

Research output: Contribution to journalArticle

39 Scopus citations
Original languageEnglish (US)
Pages (from-to)94-110
Number of pages17
JournalJournal of Law and the Biosciences
Volume1
Issue number3
DOIs
StatePublished - Sep 1 2014
Externally publishedYes

ASJC Scopus subject areas

  • Law
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)
  • Medicine (miscellaneous)

Cite this

Caulfield, T., Burningham, S., Joly, Y., Master, Z., Shabani, M., Borry, P., Becker, A., Burgess, M., Calder, K., Critchley, C., Edwards, K., Fullerton, S. M., Gottweis, H., Hyde-Lay, R., Illes, J., Isasi, R., Kato, K., Kaye, J., Knoppers, B., ... Zawati, M. H. (2014). A review of the key issues associated with the commercialization of biobanks. Journal of Law and the Biosciences, 1(3), 94-110. https://doi.org/10.1093/jlb/lst004